SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-20-000286
Filing Date
2020-11-06
Accepted
2020-11-06 13:23:36
Documents
28
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cncl1104form10q.htm 10-Q 152523
2 EXHIBIT 31.1 cncl1104form10qexh31_1.htm EX-31.1 8208
3 EXHIBIT 31.2 cncl1104form10qexh31_2.htm EX-31.2 8200
4 EXHIBIT 32.1 cncl1104form10qexh32_1.htm EX-32.1 4028
  Complete submission text file 0001554795-20-000286.txt   754944

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cncl-20200930.xml EX-101.INS 64860
6 XBRL SCHEMA FILE cncl-20200930.xsd EX-101.SCH 8648
7 XBRL CALCULATION FILE cncl-20200930_cal.xml EX-101.CAL 18436
8 XBRL DEFINITION FILE cncl-20200930_def.xml EX-101.DEF 10339
9 XBRL LABEL FILE cncl-20200930_lab.xml EX-101.LAB 77746
10 XBRL PRESENTATION FILE cncl-20200930_pre.xml EX-101.PRE 56927
Mailing Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

IRS No.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32363 | Film No.: 201293564
SIC: 6770 Blank Checks